[Pediatric endocrinological service in the Russian Federation: current state and development prospects]

O B Bezlepkina1

  • 1Endocrinology Research Centre.

Problemy Endokrinologii
|December 28, 2020
PubMed

Insights

This study reviews pediatric endocrinology care in the Russian Federation, detailing disease prevalence and healthcare resources. It outlines the current state of pediatric endocrine services and specialists available.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Healthcare Management

Background:

  • Endocrine diseases in children represent a significant public health concern.
  • Effective management requires understanding disease prevalence and healthcare infrastructure.
  • Regulatory frameworks are crucial for standardized pediatric endocrine care.

Purpose of the Study:

  • To present data on the prevalence of endocrine diseases in children within the Russian Federation.
  • To outline the key normative documents governing pediatric endocrinology services.
  • To assess the current status of healthcare resources, including beds, departments, and specialists.

Main Methods:

  • Data compilation on disease prevalence.
  • Review of legislative and normative acts.
  • Analysis of healthcare infrastructure statistics (bed fund, specialized departments).
  • Assessment of the number of pediatric endocrinologists.

Main Results:

  • The article presents data on the prevalence of pediatric endocrine diseases.
  • Key regulatory documents for pediatric endocrinology are identified.
  • Information on the availability of children's endocrinology beds and specialized departments is provided.
  • The number of practicing pediatric endocrinologists is reported.

Conclusions:

  • The study highlights the need for robust data on pediatric endocrine disease prevalence.
  • Adequate healthcare resources and specialist numbers are essential for quality care.
  • Compliance with normative documents ensures standardized and effective treatment protocols.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
109
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
132
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
109
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
61